RTX is in a recovery-within-a-range posture rather than a clean uptrend: the stock is up 6.45% over the past year but sits at $191.01, which is only about 46% of the way through its 52-week range of $166.74 to $226.88, meaning it is closer to the middle of the band than to either extreme. That positioning reflects a stock that has given back a large portion of its mid-summer gains — the 52-week high of $226.88 was set in August — while still holding above its 52-week low by roughly 14.6%. The 20.06% maximum drawdown confirms this has been a volatile, two-way tape rather than a steady compounding trend, and the current price is essentially flat versus the 180-day starting point of $173.38, underscoring a year of round-tripping rather than directional progress. Recent momentum is clearly negative and diverging from the longer-term picture: the stock is down 0.61% over the past month and down 10.24% over three months, versus a 1-year gain of 6.45%, a classic deceleration pattern in which the intermediate trend has rolled over while the trailing-year return remains positive. Relative strength tells the same story — RTX has underperformed SPY by 13.09 percentage points over three months and 6.68 points over one year, though it outperformed by 3.16 points over six months, suggesting the weakness is concentrated in the most recent quarter. The most recent session was also weak, with the stock falling 1.90% from $194.71 to $191.01 on volume of about 5.19 million shares, and the 1-month relative strength of +0.41 points versus SPY indicates only marginal stabilization rather than a turn. Key levels are well defined: support sits at the 52-week low of $166.74, roughly 12.7% below the current price, while resistance is the 52-week high of $226.88, about 18.8% above; a breakout above that high would signal the market has fully digested the summer pullback and re-rated the backlog story, whereas a breakdown below $166.74 would confirm the three-month downtrend and likely trigger momentum-driven selling. Volatility is unusually low for an industrial: the beta of 0.308 implies the stock moves only about 31% as much as the market, which argues for smaller position-sizing adjustments than a high-beta name would require, but the 20.06% max drawdown shows that low beta has not insulated holders from sharp, idiosyncratic drawdowns.

Revenue is growing at a healthy clip and, importantly, the trend is stable to improving: Q2 2026 revenue was $24.708 billion, up 14.49% year over year from $21.581 billion in Q2 2025, and the trailing four quarters total roughly $93.5 billion. The sequential path — $22.076 billion in Q1 2026, $24.238 billion in Q4 2025, $22.478 billion in Q3 2025 — shows no deterioration, and the segment mix is balanced, with Pratt & Whitney at $8.889 billion, Raytheon Intelligence & Space at $8.269 billion, and Collins Aerospace at $8.210 billion in the reported period. That diversification matters: commercial aftermarket strength at Collins and Pratt offsets defense program timing at Raytheon, and the record backlog provides unusually high revenue visibility. The growth trend supports the investment case, but the 14.49% YoY rate is flattered by easy comparisons and will be harder to sustain, so the market will increasingly focus on backlog conversion and margin rather than top-line growth alone. Profitability is solid but not exceptional: Q2 2026 net income was $2.139 billion on a net margin of 8.66%, with gross margin of 20.77% and operating margin of 11.38%, and the company is clearly profitable with EPS of $1.58 in the quarter. Margins have been remarkably stable — gross margin was 20.81% in Q1 2026, 19.46% in Q4 2025, and 20.38% in Q3 2025 — which is a double-edged signal: it shows pricing discipline and cost control, but it also means there has been no meaningful margin expansion despite 14%+ revenue growth, suggesting mix and cost inflation are offsetting operating leverage. The net margin of 8.66% is roughly in line with what is typical for large diversified aerospace and defense primes, where mid-single-digit to high-single-digit net margins are the norm, so RTX is neither a margin standout nor a laggard. Balance sheet and cash flow are the strongest part of the story: free cash flow TTM is $12.019 billion, Q2 2026 operating cash flow was $4.159 billion against capex of $571 million for FCF of $3.588 billion, and the debt-to-equity ratio of 0.6055 is moderate for a company of this scale. The current ratio of 1.026 is thin but adequate, ROE of 10.32% and ROA of 4.56% are respectable rather than spectacular, and the dividend consumes a payout ratio of 53.1% of earnings, leaving ample room for reinvestment. The key takeaway is that RTX funds its growth internally — $12 billion of TTM FCF against roughly $2.3 billion of annual dividends — so financial risk is low, and the main cash flow question is working capital volatility, which swung sharply between quarters.